Open AccessCefoperazone-sulbactam plus amikacin empirical therapy for febrile neutropenia in children with cancer
Author(s) -
İbrahim Bayram,
Fatih Erbey,
Derya Alabaz,
Sema Yılmaz,
Atila Tanyeli
Publication year - 2009
Publication title -
turkish journal of medical sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.277
H-Index - 27
eISSN - 1303-6165
pISSN - 1300-0144
DOI - 10.3906/sag-0806-14
Subject(s) - medicine , amikacin , febrile neutropenia , neutropenia , cefoperazone , sulbactam , antibiotics , pediatric cancer , refractory (planetary science) , adverse effect , surgery , cancer , chemotherapy , antibiotic resistance , microbiology and biotechnology , physics , imipenem , astrobiology , biology
doi:10.3906/sag-0806-14 Cefoperazone-sulbactam plus amikacin empirical therapy for febrile neutropenia in children with cancer Aim: To determine the efficacy and safety of cefoperazone-sulbactam combined with amikacin in the treatment of febrile neutropenia in children with cancer. Materials and Methods: The study included 20 cancer cases with 26 febrile neutropenia (FEN) episodes. Patient selection criteria were defined according to the guidelines issued by the Infectiou